The Top 60: S&R Communications Group

Share this article:
Asked about their top priorities for the remainder of 2008 and beyond, most agency prexies don't wait for the question to end before they start spewing the words “interactive” and “digital.” But when the same question is put to Paul Dreyer, president and COO of S&R Communications Group, his answer has a decidedly more old-school bent.

S&R remains committed to targeting primary care physicians first and foremost. “With all the changes in healthcare, obviously physicians aren't the key decision-makers anymore,” he says. “We get that. But if you get the communications and message right with physicians, that's the most important first step.”
Which isn't to say that S&R has let the interactive/ digital bandwagon pass it by. The company grew its capabilities during the last year by hiring new staffers and striving to educate existing ones.

Dreyer, like just about everybody else, bemoans the pressure that the industry has faced in recent months. Still, S&R has weathered the storm, remaining about the same size (50 staffers across S&R and spun-off CME-focused sister firm Scienta Healthcare Education) despite the loss of a key client, Sepracor.

S&R had worked with Sepracor for around seven years and Dreyer admits that the loss “put a lot of pressure on us, because we had to fill the revenue loss.” That said, the firm hasn't resorted to layoffs, thanks to big successes on the new-business front. Wins included Inspire Pharmaceuticals (for the AzaSite launch) and Prestwick Pharmaceuticals (for the Xenazine launch). Siemens Medical and Mattson Jack Group tapped S&R for a range of corporate work and communications, while Sciele Pharma hired the firm to tout Zovirax.

As for the future, Dreyer expects another challenging year for the business as a whole.
Share this article:
You must be a registered member of MMM to post a comment.

Email Newsletters

MM&M Future Leaders

Register now

Early bird $1,950 before 31 October 2014

*Group discounts available on request 


Patient access to pharmaceuticals is a tale of two worlds—affordability has improved for the majority, while the minority is hampered by cost, distribution and red tape. To provide marketers with a well-rounded perspective, MM&M presents this e-book chock full of key insights. Click here to access it.

More in Features

Read the complete October 2014 Digital Edition

Read the complete October 2014 Digital Edition

Click the above link to access the complete Digital Edition of the October 2014 issue of MM&M, with all text, charts and pictures.

Predicting your pink slip

Predicting your pink slip

Any time a firm needs to save money, high-salaried executives are targets

Private View: New ways to engage with customers

Private View: New ways to engage with customers

These healthcare social media campaigns successfully use emotion, altruism and the human desire to "brand" oneself to get customers engaged.